Table 1. Clinical parameters of different study subgroups.
| Non-ACS (n = 472) | Whole ACS (N = 1094) | p value | MI (n = 784) | p value* | UA (n = 310) | p value# | |
| Gender (male) | 238 (50.4) | 778 (71.1) | < 0.001 | 567 (72.3) | < 0.001 | 211 (68.1) | < 0.001 |
| Age (y/o) | 62 ± 13 | 69 ± 13 | < 0.001 | 69 ± 14 | < 0.001 | 69 ± 12 | < 0.001 |
| BMI (Kg/m2) | N/A | 25 ± 4 | N/A | 25 ± 4 | N/A | 25 ± 4 | N/A |
| Smoking | N/A | 314 (28.7) | N/A | 252 (32.1) | N/A | 62 (20.0) | N/A |
| DM | 134 (28.4) | 562 (51.4) | < 0.001 | 395 (50.4) | < 0.001 | 167 (53.9) | < 0.001 |
| HTN | 248 (52.5) | 747 (68.3) | < 0.001 | 518 (66.1) | < 0.001 | 229 (73.9) | < 0.001 |
| DL | 162 (34.3) | 584 (53.4) | < 0.001 | 397 (50.6) | < 0.001 | 187 (60.3) | < 0.001 |
| CKD | 74 (15.7) | 458 (41.9) | < 0.001 | 349 (44.5) | < 0.001 | 109 (35.2) | < 0.001 |
| WBC (103/uL) | 7.5 ± 2.9 | 10.5 ± 4.8 | < 0.001 | 11.4 ± 5.1 | < 0.001 | 8.3 ± 3.1 | 0.001 |
| Hb (106/uL) | 13.2 ± 1.8 | 12.8 ± 2.5 | < 0.001 | 12.9 ± 2.6 | 0.005 | 12.5 ± 2.1 | < 0.001 |
| Plt (103/uL) | 219 ± 63 | 217 ± 75 | 0.502 | 218 ± 77 | 0.748 | 214 ± 69 | 0.265 |
| MPV (fL) | 8.4 ± 1.0 | 8.6 ± 1.1 | 0.007 | 8.6 ± 1.1 | 0.002 | 8.5 ± 1.1 | 0.283 |
| Cr (mg/dL) | 1.17 ± 1.33 | 2.13 ± 2.50 | < 0.001 | 2.20 ± 2.59 | < 0.001 | 1.97 ± 2.24 | < 0.001 |
| LDL (mg/dL) | 51 ± 17 | 112 ± 41 | < 0.001 | 113 ± 43 | < 0.001 | 109 ± 38 | < 0.001 |
| HbA1C (%) | 6.2 ± 1.3 | 6.7 ± 1.6 | < 0.001 | 6.7 ± 1.6 | 0.001 | 6.8 ± 1.6 | 0.001 |
Data are presented as mean ± SD or N (%). * Compare non-ACS group and MI group. # Compare non-ACS group and UA group.
ACS, acute coronary syndrome; BMI, body mass index; CKD, chronic kidney disease; Cr, creatinine; DL, dyslipidemia; DM, diabetes mellitus; Hb, hemoglobin; HTN, hypertension; LDL, low-density lipoprotein; MI, myocardial infarction; MPV, mean platelet volume; Plt, platelet; SD, standard deviation; UA, unstable angina; WBC, white blood cell.